Investors continue to be optimistic about Chemed (CHE) on the strength of the VITAS Healthcare and Roto-Rooter segments.
Within the Hospice segment, Chemed (CHE) is well poised to register growth driven by the growing aging population.
CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (NYSE:CHE) today announced that it will deliver a presentation at the 42nd Annual JPMorgan Healthcare Conference on Monday, January 8, 2024, at approxim
Investors looking for stocks in the Medical - Outpatient and Home Healthcare sector might want to consider either DaVita HealthCare (DVA) or Chemed (CHE). But which of these two stocks offers value in
David Wagner, portfolio manager at Aptus Capital Advisors, joins 'Power Lunch' to discuss three stocks: Cintas, Chemed and CrowdStrike.
Investors with an interest in Medical - Outpatient and Home Healthcare stocks have likely encountered both DaVita HealthCare (DVA) and Chemed (CHE). But which of these two companies is the best option
CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (NYSE:CHE) today announced that it will present at the BofA Securities 2023 Virtual Home Care Conference on Monday, December 4, 2023, at 2:10 PM (ET). T
Chemed Corporation has historically matched long-term returns with minimal drawdown periods and durable economics. CHE has shown significant market growth over the years, compounding returns on shareh
Chemed (CHE) believes Roto-Rooter is well-positioned for growth and anticipates continued expansion of the segment's market share.
Investors interested in Medical - Outpatient and Home Healthcare stocks are likely familiar with DaVita HealthCare (DVA) and Chemed (CHE). But which of these two stocks offers value investors a better
Chemed's (CHE) third-quarter 2023 performance reflects strength in the VITAS segment.
Chemed Corporation (NYSE:CHE ) Q3 2023 Earnings Conference Call October 26, 2023 10:00 AM ET Company Participants Holley Schmidt - Assistant Controller Kevin McNamara - President and Chief Executive O
The headline numbers for Chemed (CHE) give insight into how the company performed in the quarter ended September 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estima
Chemed (CHE) came out with quarterly earnings of $5.32 per share, beating the Zacks Consensus Estimate of $4.92 per share. This compares to earnings of $4.74 per share a year ago.
Investors interested in stocks from the Medical - Outpatient and Home Healthcare sector have probably already heard of Option Care (OPCH) and Chemed (CHE). But which of these two stocks offers value i
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE